Last update 21 Nov 2024

CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy)

Overview

Basic Info

Drug Type
CAR-T
Synonyms-
Target
CD19 x CD22
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD22 inhibitors(CD22 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesInfectious Diseases+ [5]
Active Indication-
Inactive Indication
Burkitt LymphomaCarney ComplexCD19-positive B-cell acute lymphoblastic leukemia+ [1]
Originator Organization
Shenzhen University General Hospital
Active Organization-
Inactive Organization
Shenzhen University General Hospital
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy)
NCT04723901 / Unknown statusPhase 1/2IIT
Clinical Trial of CD19/CD22 Dual Target CAR-T Cells in the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
100 Clinical Results associated with CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy)
Login to view more data
100 Translational Medicine associated with CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy)
Login to view more data
100 Patents (Medical) associated with CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy)
Login to view more data
100 Deals associated with CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Burkitt LymphomaPhase 2
CN
Shenzhen University General Hospital
20 Oct 2020
Carney ComplexPhase 2
CN
Shenzhen University General Hospital
20 Oct 2020
CD19-positive B-cell acute lymphoblastic leukemiaPhase 2
CN
Shenzhen University General Hospital
20 Oct 2020
Refractory B Acute Lymphoblastic LeukemiaPhase 2
CN
Shenzhen University General Hospital
20 Oct 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free